Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosseti South reported for 2023 by IFRS

3/18/24 MRKY

Rosseti Center and Volga Region reported for 2023 by IFRS

3/18/24 MRKP

Rosseti Center and Volga Region reported for 2023 by RAS

3/18/24 MRKP

Rosseti Center reported for 2023 by IFRS

3/18/24 MRKC

Rosseti Center reported for 2023 by RAS

3/18/24 MRKC

Rosseti Volga reported for 2023 by IFRS

3/18/24 MRKV

Rosseti Volga reported for 2023 by RAS

3/18/24 MRKV

Lukoil's oil is transported through the CPC by a new trader Litasco Middle East

3/18/24 LKOH

Rosseti Urals reported for 2023 by IFRS

3/18/24 MRKU

Rosseti Urals reported for 2023 by RAS

3/18/24 MRKU